Eyal C. Attar, the CHIEF MEDICAL OFFICER of $VOR ($VOR), sold 10,334 shares of the company on 12-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.3% of their shares. Following this trade, they now own 81,439 shares of $VOR stock.
$VOR Insider Trading Activity
$VOR insiders have traded $VOR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here's a breakdown of recent trading of $VOR stock by insiders over the last 6 months:
- EYAL C. ATTAR (CHIEF MEDICAL OFFICER) sold 10,334 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VOR Hedge Fund Activity
We have seen 17 institutional investors add shares of $VOR stock to their portfolio, and 45 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARADIGM BIOCAPITAL ADVISORS LP removed 6,457,293 shares (-100.0%) from their portfolio in Q3 2024
- LAURION CAPITAL MANAGEMENT LP removed 2,496,468 shares (-98.9%) from their portfolio in Q3 2024
- HUDSON BAY CAPITAL MANAGEMENT LP added 2,466,236 shares (+inf%) to their portfolio in Q3 2024
- COWEN AND COMPANY, LLC added 1,220,590 shares (+inf%) to their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC removed 347,115 shares (-92.5%) from their portfolio in Q3 2024
- NORTHERN TRUST CORP removed 267,378 shares (-70.2%) from their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC added 260,711 shares (+52.6%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.